CRESCENTIC GLOMERULONEPHRITIS

Clinical trials for CRESCENTIC GLOMERULONEPHRITIS explained in plain language.

Never miss a new study

Get alerted when new CRESCENTIC GLOMERULONEPHRITIS trials appear

Sign up with your email to follow new studies for CRESCENTIC GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a diabetes drug shield kidneys from autoimmune attack?

Disease control Recruiting now

This trial investigates whether pioglitazone, a drug used for diabetes, can help protect the kidneys in people with ANCA-associated vasculitis—a rare autoimmune disease that causes inflammation of blood vessels, often damaging the kidneys. Participants receive either pioglitazone…

Matched conditions: CRESCENTIC GLOMERULONEPHRITIS

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jul 01, 2026 23:00 UTC

CRESCENTIC GLOMERULONEPHRITIS

Get alerted when new CRESCENTIC GLOMERULONEPHRITIS trials appear

Could a diabetes drug shield kidneys from autoimmune attack?